Do mCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer?
MCM2 is a sensitive, specific and efficient biomarker of GCC having potential use in clinic.
Consistent with previous research, significant cross-sectional and prospective associations were found between MDD and ANX. The results of the present study suggest that different etiological models may characterize the co-morbidity between MDD and ANX based upon the temporal order of onset. Implications for classification and prevention efforts are discussed.